Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seetal Dodd

Showing results (11-20 of 251) with videos related to

Pageof 26
Sort By:
Expert Opinion on Investigational Drugs|October 2, 2003
Recent developments in the treatment of bipolar disordersMichael Berk, Seetal Dodd
Current Drug Safety|August 12, 2008
The safety of medications for the treatment of bipolar disorder during pregnancy and the puerperiumSeetal Dodd, Michael Berk
Medical Hypotheses|May 17, 2005
Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?Michael Berk, Seetal Dodd
Expert Review of Neurotherapeutics|September 2, 2008
Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utilitySeetal Dodd, Michael Berk
Evidence-Based Mental Health|July 27, 2004
Review: rapid cycling bipolar disorder associated with female gender and bipolar type II subgroupMichael Berk, Seetal Dodd
Human Psychopharmacology|December 23, 2004
Antidepressants and adolescents: the bipolar confound?Michael Berk, Seetal Dodd
Evidence-Based Mental Health|January 27, 2007
Higher dose venlafaxine may improve response compared with standard doses in people with major depressive disorder and intolerance or non-responsiveness to SSRIsSeetal Dodd, Michael Berk
Expert Opinion on Drug Safety|May 25, 2004
The pharmacology of bipolar disorder during pregnancy and breastfeedingSeetal Dodd, Michael Berk
Bipolar Disorders|January 19, 2005
Bipolar II disorder: a reviewMichael Berk, Seetal Dodd
Drugs|January 6, 2005
Efficacy of atypical antipsychotics in bipolar disorderMichael Berk, Seetal Dodd
Pageof 26

Showing results (11-20 of 251) with videos related to

Sort By:
Pageof 26
Expert Opinion on Investigational Drugs|October 2, 2003
Recent developments in the treatment of bipolar disordersMichael Berk, Seetal Dodd
Current Drug Safety|August 12, 2008
The safety of medications for the treatment of bipolar disorder during pregnancy and the puerperiumSeetal Dodd, Michael Berk
Medical Hypotheses|May 17, 2005
Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?Michael Berk, Seetal Dodd
Expert Review of Neurotherapeutics|September 2, 2008
Olanzapine/fluoxetine combination for treatment-resistant depression: efficacy and clinical utilitySeetal Dodd, Michael Berk
Evidence-Based Mental Health|July 27, 2004
Review: rapid cycling bipolar disorder associated with female gender and bipolar type II subgroupMichael Berk, Seetal Dodd
Human Psychopharmacology|December 23, 2004
Antidepressants and adolescents: the bipolar confound?Michael Berk, Seetal Dodd
Evidence-Based Mental Health|January 27, 2007
Higher dose venlafaxine may improve response compared with standard doses in people with major depressive disorder and intolerance or non-responsiveness to SSRIsSeetal Dodd, Michael Berk
Expert Opinion on Drug Safety|May 25, 2004
The pharmacology of bipolar disorder during pregnancy and breastfeedingSeetal Dodd, Michael Berk
Bipolar Disorders|January 19, 2005
Bipolar II disorder: a reviewMichael Berk, Seetal Dodd
Drugs|January 6, 2005
Efficacy of atypical antipsychotics in bipolar disorderMichael Berk, Seetal Dodd
Pageof 26